REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
year | Average | Low | High | Change from close on 2022-08-12 |
---|---|---|---|---|
2022 | $517.68 | $471.53 | $580.75 | -17.66% |
2023 | $448.24 | $347.31 | $502.07 | -28.7% |
2024 | $284.18 | $259.42 | $331.55 | -54.8% |
2025 | $275.42 | $261.08 | $285.12 | -56.19% |
2026 | $306.24 | $285.91 | $355.44 | -51.29% |
2027 | $379.79 | $369.19 | $397.15 | -39.59% |
2028 | $450.55 | $405.02 | $504.47 | -28.34% |
2029 | $542.06 | $516.9 | $558.57 | -13.78% |
2030 | $552.94 | $551.36 | $555.62 | -12.05% |
2031 | $553.74 | $551.54 | $557.62 | -11.92% |
2032 | $561.73 | $558.67 | $564.38 | -10.65% |
The 10 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$668.1 with a high forecast of $760.0 and a low forecast of $536.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 6.27%
increase from the last price of $628.710021972656.
From AI system, total return is 3178.18% from 3810 forecasts.
For REGENERON PHARMACEUTICALS stock forecast for 2022, 4 predictions are offered for each month of 2022 with average REGENERON PHARMACEUTICALS stock
forecast of $517.68, a high forecast of $580.75, and a low forecast of $471.53.
The average REGENERON PHARMACEUTICALS stock forecast 2022 represents a -17.66%
decrease from the last price of $628.710021972656.
For REGENERON PHARMACEUTICALS stock forecast for 2023, 12 predictions are offered for each month of 2023 with average REGENERON PHARMACEUTICALS stock
forecast of $448.24, a high forecast of $502.07, and a low forecast of $347.31.
The average REGENERON PHARMACEUTICALS stock forecast 2023 represents a -28.7%
decrease from the last price of $628.710021972656.
For REGENERON PHARMACEUTICALS stock forecast for 2025, 12 predictions are offered for each month of 2025 with average REGENERON PHARMACEUTICALS stock
forecast of $275.42, a high forecast of $285.12, and a low forecast of $261.08.
The average REGENERON PHARMACEUTICALS stock forecast 2025 represents a -56.19%
decrease from the last price of $628.710021972656.
For REGENERON PHARMACEUTICALS stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average REGENERON PHARMACEUTICALS stock
forecast of $379.79, a high forecast of $397.15, and a low forecast of $369.19.
The average REGENERON PHARMACEUTICALS stock forecast 2027 represents a -39.59%
decrease from the last price of $628.710021972656.
For REGENERON PHARMACEUTICALS stock forecast for 2030, 12 predictions are offered for each month of 2030 with average REGENERON PHARMACEUTICALS stock
forecast of $552.94, a high forecast of $555.62, and a low forecast of $551.36.
The average REGENERON PHARMACEUTICALS stock forecast 2030 represents a -12.05%
decrease from the last price of $628.710021972656.
For REGENERON PHARMACEUTICALS stock forecast for 2032 (10 year), 8 predictions are offered for each month of 2032 with average REGENERON PHARMACEUTICALS stock
forecast of $561.73, a high forecast of $564.38, and a low forecast of $558.67.
The average REGENERON PHARMACEUTICALS stock forecast 2032 represents a -10.65%
decrease from the last price of $628.710021972656.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $668.1, and this show a 1.77% increase in average from the prior price target of the each prediction. Also, this average forecast of $668.1 represents a -6.6% decrease from the past average forecast of $715.28, 6 months ago from 18 wall street analysts.
REGENERON PHARMACEUTICALS stock forecast for upcoming days
Date | Price Target | Change |
---|---|---|
2022-08-16 | $626.08 | -0.42% |
2022-08-17 | $612.07 | -2.24% |
2022-08-18 | $605.15 | -1.13% |
2022-08-19 | $607.77 | 0.43% |
2022-08-22 | $605.73 | -0.34% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Sep. is $580.75 , for 2023 Aug. is $443.22 , for 2026 Aug. is $306.39 , for 2027 Aug. is $369.44 , for 2031 Aug. is $554.09 , and for 2032 Aug. is $564.38.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2022
Date | Price Target | Change |
---|---|---|
2022 Sep. | $580.75 | -7.63% |
2022 Oct. | $528.81 | -8.94% |
2022 Nov. | $489.62 | -7.41% |
2022 Dec. | $471.53 | -3.69% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2023
Date | Price Target | Change |
---|---|---|
2023 Jan. | $471.54 | 0.00% |
2023 Feb. | $482.39 | 2.30% |
2023 Mar. | $496.21 | 2.86% |
2023 Apr. | $502.07 | 1.18% |
2023 May. | $495.61 | -1.29% |
2023 Jun. | $481.22 | -2.90% |
2023 Jul. | $463.65 | -3.65% |
2023 Aug. | $443.22 | -4.41% |
2023 Sep. | $422.15 | -4.75% |
2023 Oct. | $400.22 | -5.19% |
2023 Nov. | $373.33 | -6.72% |
2023 Dec. | $347.31 | -6.97% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2024
Date | Price Target | Change |
---|---|---|
2024 Jan. | $331.55 | -4.54% |
2024 Feb. | $320.14 | -3.44% |
2024 Mar. | $309.51 | -3.32% |
2024 Apr. | $297.07 | -4.02% |
2024 May. | $287.21 | -3.32% |
2024 Jun. | $280.23 | -2.43% |
2024 Jul. | $273.70 | -2.33% |
2024 Aug. | $267.90 | -2.12% |
2024 Sep. | $263.01 | -1.82% |
2024 Oct. | $260.37 | -1.00% |
2024 Nov. | $259.42 | -0.36% |
2024 Dec. | $260.07 | 0.25% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
Date | Price Target | Change |
---|---|---|
2025 Jan. | $261.08 | 0.39% |
2025 Feb. | $262.29 | 0.46% |
2025 Mar. | $264.24 | 0.74% |
2025 Apr. | $270.29 | 2.29% |
2025 May. | $274.69 | 1.63% |
2025 Jun. | $277.26 | 0.94% |
2025 Jul. | $279.15 | 0.68% |
2025 Aug. | $280.80 | 0.59% |
2025 Sep. | $282.31 | 0.54% |
2025 Oct. | $283.46 | 0.41% |
2025 Nov. | $284.34 | 0.31% |
2025 Dec. | $285.12 | 0.27% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
Date | Price Target | Change |
---|---|---|
2026 Jan. | $285.91 | 0.28% |
2026 Feb. | $286.80 | 0.31% |
2026 Mar. | $288.03 | 0.43% |
2026 Apr. | $289.81 | 0.62% |
2026 May. | $292.44 | 0.91% |
2026 Jun. | $296.10 | 1.25% |
2026 Jul. | $300.73 | 1.56% |
2026 Aug. | $306.39 | 1.88% |
2026 Sep. | $313.31 | 2.26% |
2026 Oct. | $323.02 | 3.10% |
2026 Nov. | $336.90 | 4.30% |
2026 Dec. | $355.44 | 5.51% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
Date | Price Target | Change |
---|---|---|
2027 Jan. | $375.68 | 5.69% |
2027 Feb. | $389.06 | 3.56% |
2027 Mar. | $388.84 | -0.06% |
2027 Apr. | $379.15 | -2.49% |
2027 May. | $373.37 | -1.52% |
2027 Jun. | $371.41 | -0.53% |
2027 Jul. | $369.19 | -0.60% |
2027 Aug. | $369.44 | 0.07% |
2027 Sep. | $373.85 | 1.19% |
2027 Oct. | $381.13 | 1.95% |
2027 Nov. | $389.19 | 2.12% |
2027 Dec. | $397.15 | 2.05% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
Date | Price Target | Change |
---|---|---|
2028 Jan. | $405.02 | 1.98% |
2028 Feb. | $412.97 | 1.96% |
2028 Mar. | $420.89 | 1.92% |
2028 Apr. | $428.49 | 1.81% |
2028 May. | $435.98 | 1.75% |
2028 Jun. | $443.48 | 1.72% |
2028 Jul. | $451.50 | 1.81% |
2028 Aug. | $460.35 | 1.96% |
2028 Sep. | $470.15 | 2.13% |
2028 Oct. | $480.92 | 2.29% |
2028 Nov. | $492.36 | 2.38% |
2028 Dec. | $504.47 | 2.46% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
Date | Price Target | Change |
---|---|---|
2029 Jan. | $516.90 | 2.46% |
2029 Feb. | $528.89 | 2.32% |
2029 Mar. | $539.37 | 1.98% |
2029 Apr. | $548.03 | 1.61% |
2029 May. | $555.42 | 1.35% |
2029 Jun. | $558.57 | 0.57% |
2029 Jul. | $538.90 | -3.52% |
2029 Aug. | $528.55 | -1.92% |
2029 Sep. | $535.56 | 1.32% |
2029 Oct. | $546.46 | 2.04% |
2029 Nov. | $552.89 | 1.18% |
2029 Dec. | $555.15 | 0.41% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
Date | Price Target | Change |
---|---|---|
2030 Jan. | $555.62 | 0.09% |
2030 Feb. | $555.38 | -0.04% |
2030 Mar. | $554.81 | -0.10% |
2030 Apr. | $554.07 | -0.13% |
2030 May. | $553.31 | -0.14% |
2030 Jun. | $552.64 | -0.12% |
2030 Jul. | $552.12 | -0.09% |
2030 Aug. | $551.73 | -0.07% |
2030 Sep. | $551.38 | -0.06% |
2030 Oct. | $551.36 | -0.00% |
2030 Nov. | $551.38 | 0.01% |
2030 Dec. | $551.45 | 0.01% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
Date | Price Target | Change |
---|---|---|
2031 Jan. | $551.54 | 0.02% |
2031 Feb. | $551.68 | 0.03% |
2031 Mar. | $551.87 | 0.03% |
2031 Apr. | $552.13 | 0.05% |
2031 May. | $552.47 | 0.06% |
2031 Jun. | $552.90 | 0.08% |
2031 Jul. | $553.44 | 0.10% |
2031 Aug. | $554.09 | 0.12% |
2031 Sep. | $554.84 | 0.14% |
2031 Oct. | $555.68 | 0.15% |
2031 Nov. | $556.62 | 0.17% |
2031 Dec. | $557.62 | 0.18% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
Date | Price Target | Change |
---|---|---|
2032 Jan. | $558.67 | 0.19% |
2032 Feb. | $559.69 | 0.18% |
2032 Mar. | $560.61 | 0.16% |
2032 Apr. | $561.47 | 0.15% |
2032 May. | $562.27 | 0.14% |
2032 Jun. | $563.02 | 0.13% |
2032 Jul. | $563.72 | 0.12% |
2032 Aug. | $564.38 | 0.12% |
Financial Data for REGENERON PHARMACEUTICALS stock
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2022 Sep. is $580.745782641935 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2023 Aug. is $443.220400387989 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2026 Aug. is $306.389075616218 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2027 Aug. is $369.443778963704 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2031 Aug. is $554.085942930982 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AI Pickup, the REGENERON PHARMACEUTICALS stock price forecast for 2032 Aug. is $564.378912471901
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go DOWN . Therefore, AI Pickup would say that REGENERON PHARMACEUTICALS (REGN) stock is overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
No. The REGENERON PHARMACEUTICALS stock price forecast for 2023 Aug. is $443.220400387989
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2022-08-12 is $628.710021972656 and forecast for 2023 Aug. is $443.22, REGENERON PHARMACEUTICALS stock is not a good 1 year investment.